Home » Authors » Brady Huggett

Articles by Brady Huggett

Avant Dropping TP10 Following Phase II Failure; Stock Tumbles

Feb. 21, 2002

By Brady Huggett

Vela Raises $25M In Series D To Fund Trials, Add Employees

Feb. 20, 2002

By Brady Huggett

Vela Raises $25M In Series D To Fund Trials, Add Employees

Feb. 20, 2002

By Brady Huggett

Amylin Raises $84M Publicly To Fund AC2993 Phase III Trials

Feb. 13, 2002

By Brady Huggett

Amylin Raises $84M Publicly To Fund AC2993 Phase III Trials

Feb. 13, 2002

By Brady Huggett

Deltagen Paying $23.5M For BMS Unit, Adding Discovery Capability

Feb. 12, 2002

By Brady Huggett

Deltagen Paying $23.5M For BMS Unit, Adding Discovery Capability

Feb. 12, 2002

By Brady Huggett

Immunex, Genesis Form Pact To Research, Develop Molecules

Feb. 8, 2002

By Brady Huggett

Immunex, Genesis Form Pact To Research, Develop Molecules

Feb. 8, 2002

By Brady Huggett

ZymoGenetics Raises $120M In Year’s First Biotech IPO

Feb. 4, 2002

By Brady Huggett